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Liposarcoma of the spermatic cord (LSC) is a rare condition characterized by a painless inguinal or scrotal mass. To
our knowledge, only about 200 cases have been previously reported in the literature. These tumors are often
mistaken for common scrotal swellings, such as hydroceles and hernias. We present a LSC case in which a definitive
diagnosis was obtained upon histological examination. We also provide a literature review of other cases that have
been reported.
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Liposarcoma is a rare soft tissue malignancy with aggres-
sive behavior and poor prognosis. It is derived from
mesenchymal tissue and can occur in fat cells anywhere
in the body. Most malignant paratesticular tumors are
sarcomas but 5 to 7% are liposarcomas [1]. To the best
of our knowledge, only about 200 cases of liposarcoma
of the spermatic cord (LSC) have previously been
reported worldwide [1-29]. Most were reported in
adults, presenting as a painless inguinal or scrotal mass,
and were usually mistaken for an inguinal hernia or tes-
ticular hydrocele. Preoperative diagnosis was infrequent.
Hence, increasing the understanding of LSCs is particu-
larly important. Until now, the published literature on
LSC has been limited to case reports with limited clin-
ical information. Here we present a case report and a
comprehensive literature review with the objective of
providing useful information on this malignancy.Case presentation
A 53-year-old male presented with a slow-growing, pain-
less, left scrotum mass of two years duration and was ad-
mitted to the outpatient general surgery department for
hernioplasty in December 2010. The provisional diagnosis* Correspondence: whl1228@126.com
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reproduction in any medium, provided the ormade by his family practitioner was a left–sided inguinal
hernia, and the patient was referred for surgery. Physical
examination showed a large, non-tender, mobile left scrotal
mass. The mass was larger with increased abdominal pres-
sure when the patient was standing, but smaller when he
was supine. Trans-illumination testing was negative. There
were no constitutional symptoms, voiding complaints, his-
tory of local trauma, infection, weight loss or hereditary dis-
ease. All pre-operative laboratory tests, including complete
blood count, biochemistry and chest X-ray, were normal. A
pelvic computerized tomography (CT) scan was negative
for retroperitoneal metastasis. Scrotal ultrasonography (8
to 12 linear array transducer, LOGIQ P5, GE Healthcare,
New York,New York State,USA) revealed a 55 x 42 mm
mass on the left side of the inguinal canal with internal
echogenecity resembling fatty tissues and extending to the
scrotum.
The patient underwent exploratory surgery via a left in-
guinal canal approach, during which a well-defined 6 × 5 ×
3 cm round mass located above the left testis and epididy-
mis was discovered; the vas deferens was involved. Upon
close inspection, there was no evidence of hernia or laxity
in the inguinal floor. Intraoperative frozen-section biopsy
showed malignancy of the spermatic cord. A complete
radical left orchidectomy was performed with wide exci-
sion and high ligation of the spermatic cord. An ipsilateral
inguinal lymph node was also removed for biopsy.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 HE staining of LSC. Microscopically well-differentiated
myxoid liposarcoma composed of mature adipose tissue and a few
scattered lipoblasts (yellow arrow: mature fatty cells) (H&E ×400).
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with a yellowish lipoma-like texture of the cut-surface. It
was encapsulated, and attached to the spermatic cord. A
hard tumor could be palpated in the center of the mass
(Figure 1).
Histological examination confirmed a well-differentiated
myxoid liposarcoma, composed of mature adipose tissue
and a few scattered lipoblasts separated by fibrous septa
into the lobules of varying sizes. Lipoblasts with
hyperchromatic nuclei, irregularly-shaped spindle cells
and abnormal cells were present in myxoid areas
(Figure 2). The surgical margin was free of tumor. The left
inguinal sentinel lymph node biopsy showed no evidence
of metastasis. The patient had a good postoperative clin-
ical course without complications and was discharged on
the seventh postoperative day. After an 18-month follow-
up without adjuvant therapy, the patient was in good con-
dition with no evidence of recurrence. No metastasis was
seen during this period.
Discussion
Liposarcoma of paratesticular tissues (spermatic cord,
testicular tunics or epididymis), first reported in 1952
[2], is a rare neoplasm that comprises approximately 5%
to 7% of paratesticular sarcomas [3,4]. Most originate in
the spermatic cord [5] but some originate in the
retroperitoneum and develop in the inguinal region, in-
volving the spermatic cord [6]. Yoshino et al. described
a patient who developed LSC after radical prostatectomy
for prostate cancer [7]. Manzia et al. reported a case of a
renal transplant recipient in whom LSC presented on
the same side as the graft at four years post-
transplantation [8]. The tumor occurs world-wide,Figure 1 The gross appearance of LSC. Macroscopic appearance
of the surgical specimen showing an encapsulated mass of adipose
tissue and a cut surface having a yellowish lipoma-like texture. The
left testis was not infiltrated. (white arrow: normal testis; red blank
arrow: tumor tissue).although there is a remarkably high incidence among
Japanese men, who account for one fourth of published
cases. For this literature review, we searched relevant
case reports published in English that were available in
full-text. Some cases that did not contain detailed infor-
mation on treatment and outcomes were excluded. As a
result, a total of 38 cases documented in 29 published
papers were included in our review (Table 1).
The tumor occurred more frequently in adults than
children, with a range of 24 to 79 years of age and a
mean age at presentation of 61 years. Overall, 22 of 38
cases (57.9%) were 60 years of age or older. The duration
of disease ranged from one week to five years. The typ-
ical clinical manifestation of LSC was a slowly growing,
non-tender, painless, nodular mass of varying size,
located intra-scrotally above the testis or in the groin
[9]. Only a few cases presented with a painful node
[5,10-12], preoperative diagnosis was not common and
was often confused with an inguinal hernia, hydrocele or
spermatocele, or a tumor of the testis or epididymis
[2,6,10,13-19]. In the present case, the scrotal mass was
palpable when the patient was in the upright position
and disappeared when he was lying down. It was thus
easily mistaken for an inguinal hernia.
High-resolution ultrasonography, computed tomog-
raphy with contrast and magnetic resonance imaging
(MRI) have become the imaging modalities of choice for
the examination of the scrotum and its contents, and all
can provide useful information about the lipomatous na-
ture of these masses [7,12,20]. Ultrasonography typically
reveals a solid, hyperechoic, heterogenous lesion separ-
ate from the testicle and similar to benign lipomas. CT
usually demonstrates a mass with fat attenuation
intermixed with non-lipomatous septa or soft tissue
nodules [21].
Table 1 Characteristics and clinical course of published cases of liposarcoma of the spermatic cord
No. age (y) Duration Location Size (cm) Treatment Pathology Follow –up Outcome
12 53 NA L.s 6 × 7 RO WDL 3 yr Recurrence
22 70 6 mo R.s 13 × 7 × 3.5 RO WDL 6 yr Recurrence
32 34 NA L.s 1.5 × 2.5 RO WDL 4 yr NRD
42 56 10 yr L.s 8.5 × 7.5 × 4.5 RO+rad PDL, WDL 18 mo NRD
52 53 NA L.s NA RO DL 18 mo NRD
62 71 2 yr L.s NA RO WDL 3 mo NRD
75 59 5 yr L.s 50 × 27.5 × 15 (10.9 kg) RO WDL 3 yr NRD
86 60 7 mo R.s; RP 14 × 3.8 × 3.5; 24 × 10 × 8 TR; RO WDL (St) 4 yr NRD
97 71 5 mo L.s 9.5 × 5.5 RO DL 4 mo NRD
108 52 3 mo L.s 0.4 TR WDL 3 yr NRD
1110 69 1 yr L.s 16 × 6 × 5 RO+rad WDL (St) NA NA
1211 53 6 mo R.s 7.5 × 4.5 × 4 RO WDL (St) NA NA
1312 76 1 wk L.s 6 × 5 × 3 TR WDML NA NA
1413 24 6 mo R.s 5 TR WDML 1 yr NRD
1514 79 3 mo L.s 12 × 6 (730 g) RO ML 1 yr NRD
1615 60 4 yr R.s 15 × 20 (760 g) RO WDML NA NA
1716 44 1 yr L.s 20 × 15 RO WDL (St) 1 yr NRD
1817 60 6 yr R.s 5 × 4 RO WDL 3 yr NRD
1918 75 18 mo L.s 20 × 15 RO ML NA NA
2018 54 NA L.s 20 × 20 RO PL NA NA
2119 73 6 mo R.s 15 × 10 × 14 RO WDL 8 yr NRD
2219 47 NA R.s 3 RO WDL 20 mo NRD
2320 73 1 yr R.s 17 × 13 × 4 RO rad DL 2 yr NRD
2420 68 1mo R.s 8 × 6 × 6 RO WDL (St) 6 mo NRD
2522. 73 NA L.s; RP 4.1 × 3.5 × 3; 3.3 × 3.3 × 2 RO; TR NA 6 mo NRD
2623 40 NA R.s 50 × 50 × 35 (42 kg) TR WDL (St) 12 mo NRD
2724 65 NA R.s 34 × 22 × 17 (5,786 g) RO DL 48 mo NRD
2825 75 NA NA 14 × 8 × 9 RO PL NA NA
2926 47 6 mo L.s 4 × 3 × 3; 4 × 2 × 2 RO WDML; A 30 mo NRD
3027 73 18 mo L.s 10 × 8 × 7 RO ML NA NA
3129 65 1 yr R.s 14 × 8 × 5 RO WDML 3 mo NRD
3230 64 4 yr L.s 26 × 15 × 7 (785 g) RO WDL 3 mo NRD
3332 57 1.5 yr L.s 11 × 7.5 × 5 RO+rad DL 10 yr NRD
3432 60 NA R.s 3 × 1.8 × 1.5 RO WDL (St) 1 yr Recurrence
3533 57 1 yr L.s 9 × 6.5 RO+rad DL NA NA
3634 66 3 mo R.s 5 × 10 RO PDML 6 mo Metastases
3735 60 1 yr L.s 10 × 10 × 5 RO WDL (St) 3 yr Recurrence
3836 48 2 yr R.s NA RO WDL 3 yr NRD
Our case 53 2 yr L.s 6 × 5 × 3 RO WDML 18 mo NRD
Abbreviations: A, angiolipoma; DL, dedifferentiated liposarcoma; L.s, left side; ML, myxoid liposarcoma; NA, not available; NRD, no recurrence of disease; PDL,
poorly-differentiated liposarcoma; PDML, poorly-differentiated myxoid liposarcoma; PL, pleomorphic liposarcoma; rad, radiotherapy; R.s, right side; RO, radical
orchiectomy; RP, retroperitoneum; St, sclerosing type; TR, tumor resection; WDL, well-differentiated liposarcoma; WDML, well-differentiated myxoid liposarcoma.
Li et al. World Journal of Surgical Oncology 2013, 11:18 Page 3 of 5
http://www.wjso.com/content/11/1/18
Li et al. World Journal of Surgical Oncology 2013, 11:18 Page 4 of 5
http://www.wjso.com/content/11/1/18Vorstman et al. found that the neoplasms were dom-
inant on the right side [9]. However, in our literature re-
view, we found that more cases occurred on the left [21]
than on the right side [22]. Furthermore, there were
three cases in which the retroperitoneum was involved
[2,6,23], which strongly suggested that preoperative pel-
vic CT scanning was necessary to rule out the possibility
of a tumor. The tumor size ranged from 0.4 cm to 50
cm with a mean size of 12.5 cm. The tumor weights var-
ied from less than a gram to 42 kg [8,24]. Giant LSC was
reported in three cases [24-26].
Grossly, liposarcoma resembles lipoma, especially the
lipoblastic types, but the surface may show foci with a
mucinus appearance. In large tumors, multinodularity and
multilocularity of fatty or cartilaginous tissue were often
observed [12,25,27]. Histologically, liposarcomas were
divided into well differentiated, dedifferentiated (high and
low grade) and myxoid/round cell. Most LSC were low
grade, well-differentiated tumors. In the literature we
reviewed, well-differentiated liposarcoma (WDL) and
myxoid liposarcoma (ML) were the most commonly
encountered types, accounting for 48.7% (19/39) and 25.6%
(10/39), respectively. Of 19 cases with WDL, 7 patients had
a sclerosing subtype, 11 did not report a specific subtype,
and only 1 presented with a mixture of WDL and PDL.
Dedifferentiated liposarcoma (DL) and (pleomorphic
liposarcoma) PL were considered to be highly malignant,
and had an incidence of 17.9% (7/39) and 5.1% (2/39), re-
spectively. Some uncommon histological findings have been
reported. Domşa described a mixed type liposarcoma with
well differentiated major pleomorphic and minor sclerosing
components, [26]. Ikinger et al. reported a case of a well-
differentiated myxoid liposarcoma (WDML) combined with
angiolipoma [27]. Although immunohistochemical markers
were applied in several cases [13,21,26], accurate diagnoses
depended on morphological criteria.
Liposarcomas tend to spread primarily by local exten-
sion. Once diagnosed or suspected preoperatively, rad-
ical orchiectomy with wide local excision and high
ligation of the spermatic cord is recommended [28-30],
as was performed in our case. Retroperitoneal lymph
node dissection is not indicated unless there is evidence
of metastasis. The resection must be wide, and
scrotectomy may be considered in patients with high-
grade tumors to prevent local recurrence [31]. In the 38
cases reviewed, only four patients underwent tumor re-
section [8,12,13,24]. Two patients with retroperitoneal
involvement were managed by tumor resection and rad-
ical orchidectomy [6,23]. All liposarcoma types fre-
quently recur and spread by direct invasion. Only one
patient underwent multiple organ resection for an LSC
involving the left colon that obstructed the left ureter
with loss of left kidney function [2]. Liposarcoma is rela-
tively radiosensitive and radiotherapy is regarded asuseful to prevent local recurrence. However, few data are
available regarding the optimum radiation dosage.
Radiotherapy is only recommended in selected patients
whose pathological findings show intermediate or high
histological grade or recurrent form. In our review, only
four cases underwent radiotherapy because of DL or
PDL in histopathology or invasion of section margins
[2,20,32,33]. There is no consensus on the benefit of ad-
juvant chemotherapy. Given the high rate of local recur-
rence of LSC (55 to 70%), long-term periodic follow-up
is mandatory. We found that recurrence was reported in
nine cases, including five that occurred after follow-up
[2,32,34,35] and four that occurred before [2,24,32,36].
One case recurred four times after an initial inguinal
orchiectomy had been performed [2]. The average delay
until recurrence was 3.3 years with a range of 1 to 6
years.
In spite of the likelihood of recurrence, the prognosis
was satisfactory and the rate of mortality was reduced if
radical orchiectomy resulted in complete clearance with
a negative margin. Even if patients underwent incom-
plete resection, improved disease-free survival could be
achieved by re-operative wide resection [28]. Tumor size
and absence of metastasis at diagnosis remained signifi-
cant predictors of disease-specific survival [37].
The one reported death was of a patient with PDML
who developed widespread metastases after six months
follow-up and underwent chemotherapy [2]. Detailed
follow-up data and outcomes for two cases with PL were
not available. WDL and ML have relatively better
outcomes, and have not recurred with a lower grade or
in a well-differentiated form.
Conclusions
We report a rare variety of spermatic cord mass having
a misleading presentation. LSC is a very rare condition
that can be encountered in urology or outpatient general
surgery departments. It should be highly suspected in
patients experiencing recurrent hernias of the inguinal
region. Therefore, all surgeons should be aware of this
malignancy. Careful clinical and radiological examin-
ation is helpful for appropriate preoperative diagnosis.
The treatment of choice is radical orchiectomy and wide
excision with high ligation of the spermatic cord. If the
margin is in doubt, adjuvant radiotherapy is indicated.
Given the unfavorable prognosis of sarcomatous tumors
and the high frequency of recurrence, long-term periodic
follow-up is necessary.
Consent
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